Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...

The report alleges former employee Robert Valencia received $244.1 million from 2017 to 2022, primarily through subcontracts ...

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement Trial results cons ...

Chuck Webb and Mitchell Summers ran for two touchdowns each and Sacred Heart defeated Virginia Lynchburg 56-10 on Saturday.

The (OEA) has confirmed a more than $1.41 billion revenue surplus in the 2023-2025 biennium, triggering a tax surplus credit, or “kicker,” for the 2025 ...

Nov. 10 marks the 50th anniversary of the Edmund Fitzgerald wreck, perhaps the most famous of all the estimated 6,500 ships ...